Opportunity
DIBBS #SPE2DP-26-T-4114
DLA Solicitation for Fluticasone Propionate Inhalation Aerosol (7 Units)
Posted
July 15, 2026
Respond By
July 20, 2026
Identifier
SPE2DP-26-T-4114
NAICS
424210
This procurement opportunity is issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA for Fluticasone Propionate Inhalation Aerosol. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Daniel Porter - OEM Highlight: - GlaxoSmithKline, LLC is the referenced manufacturer for the requested product - Products Requested: - Fluticasone Propionate Inhalation Aerosol (NSN 6505-01-532-6922, part number NDC66993-0080-96) - 7 units required - Each unit: 220 mcg inhaler, 12GM aerosol canister, 120 metered doses per canister - Notable Requirements: - Product must comply with Medical Marking Standard No. 1A and MIL-STD-2073-1E packaging and labeling - Shelf life of 18 months required, with at least 15 months remaining at delivery - Delivery is FOB destination within 20 days of award - Fast award process indicated
Description
FLUTICASONE PROPION (QTY: 7, NSN: 6505-01-532-6922, Purchase Request: 7017480361) Approved Sources: - CAGE: 667E9, Part No: NDC66993-0080-96, Company: GLAXOSMITHKLINE, LLC